← Leaderboards
Kevin Matthew Harlen
Montana Molecular, Llc
$125,417
Attributed
$250,833
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $195.8K · FY2018–19$200K$150K$100K$50K$0
'18
'19
Funding mix
By agency
NIH$250,833 · 1
By mechanism
R43$250,833 · 1
Top collaborators
- Thomas E Hughes2 shared
Most similar at Montana Molecular, Llc
Same institution · by research overlap
- Anne Marie Quinn$2,441,945
Others in their field
Other Emerging Leaders on “S Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$249,760,384
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$220,039,059
- Kimberly Smith · Ppd Development Lp$115,671,664
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Research focus
S DiseaseCellular AssayNerve DegenerationScientistBiosensorCellular StressDisease ModelMeasurementNeurodegenerative DisordersParkinson DiseaseStressAlzheimer&AposNeuronsChronicAnimal ModelCell ModelCellsHuntington DiseaseCell DeathBrain DiseasesBasal GangliaCommercializationBrainAward
Grant awards (2)
I-Corps Proposal for Commercialization of Live Cell Assays to Identify and Interrogate Stressed Neurons in Models of Neurodegenerative Disease$55,000
R43 · FY2019 · NS · contact PI
Live Cell Assays to Identify and Interrogate Stressed Neurons in Models of Neurodegenerative Disease.$195,833
R43 · FY2018 · NS · contact PI